Dotan, A., Ben-Shabat, N., Mcgonagle, D., Amital, H., & Watad, A. (2023). POS1607 BIOLOGICS THERAPIES FOR PSORIASIS DECREASE FUTURE RISK FOR DEVELOPING PSORIATIC ARTHRITIS. Annals of the rheumatic diseases, 82(Suppl 1), 1148-1149. https://doi.org/10.1136/annrheumdis-2023-eular.4556
Citace podle Chicago (17th ed.)Dotan, A., N. Ben-Shabat, D. Mcgonagle, H. Amital, a A. Watad. "POS1607 BIOLOGICS THERAPIES FOR PSORIASIS DECREASE FUTURE RISK FOR DEVELOPING PSORIATIC ARTHRITIS." Annals of the Rheumatic Diseases 82, no. Suppl 1 (2023): 1148-1149. https://doi.org/10.1136/annrheumdis-2023-eular.4556.
Citace podle MLA (9th ed.)Dotan, A., et al. "POS1607 BIOLOGICS THERAPIES FOR PSORIASIS DECREASE FUTURE RISK FOR DEVELOPING PSORIATIC ARTHRITIS." Annals of the Rheumatic Diseases, vol. 82, no. Suppl 1, 2023, pp. 1148-1149, https://doi.org/10.1136/annrheumdis-2023-eular.4556.